• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.

作者信息

Lamy M E, Cornu C, Desmyter J

出版信息

Dev Biol Stand. 1979;43:207-13.

PMID:230111
Abstract

Since 1967, compulsory oral vaccination before 2 years of age has been nearly the only form of poliovaccination practiced in Belgium, and there have been almost no cases of polio. In recent sera from 2,225 Belgians, 2 year olds lacked demonstrable seroneutralizing antibody, in 31% for type 1, in 8% for type 2, and in 21% for type 3. The lack of antibodies grew as the children reached 11--12 years, at which age 65% lacked antibody for type 1, 15% for type 2, and 54% for type 3; only 19% had antibodies against all types. It is argued that this decline of antibodies is not due to insufficient vaccination in former years, but is a strong example of the waning of vaccine-acquired serum antibody. Antibody rates went up after age 12. The highest rates of types 1 and 3 antibodies were seen at age 20--59. There was some decrease of antibody after 60 years. Mean antibody titers paralleled positivity rates. Results of two laboratories studying different populations with different standard techniques were similar. The data support revaccination at school entrance.

摘要

相似文献

1
Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
Dev Biol Stand. 1979;43:207-13.
2
Poliomyelitis vaccines in Belgium: 20 years of experience.
Dev Biol Stand. 1979;43:187-93.
3
Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.乌拉圭7个月至39岁人群中抗脊髓灰质炎抗体的血清流行率:对未来脊髓灰质炎疫苗接种策略的影响。
Vaccine. 2009 May 5;27(20):2689-94. doi: 10.1016/j.vaccine.2009.02.042. Epub 2009 Feb 24.
4
Immunity of the Croatian population to poliomyelitis--a serosurvey.克罗地亚人群对脊髓灰质炎的免疫力——血清学调查
Acta Med Croatica. 1998;52(4-5):229-33.
5
2001 serological survey in the Czech Republic--poliomyelitis.2001年捷克共和国血清学调查——脊髓灰质炎
Cent Eur J Public Health. 2003 Dec;11 Suppl:S31-5.
6
Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.在日本对口服脊髓灰质炎减毒活疫苗两剂次接种针对1型、2型和3型野生脊髓灰质炎病毒及疫苗衍生强毒株的评估。
Scand J Infect Dis. 2008;40(3):247-53. doi: 10.1080/00365540701596003. Epub 2007 Sep 28.
7
[A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].[通过流行病学血清学调查比较三价口服脊髓灰质炎疫苗(TOPV)大规模免疫运动的效果。山东省脊髓灰质炎控制与监测协作组,山东济南]
Zhonghua Liu Xing Bing Xue Za Zhi. 1992 Oct;13(5):261-4.
8
[Status of immunity against poliomyelitis. Polio serosurvey in 1993].[脊髓灰质炎免疫状况。1993年脊髓灰质炎血清学调查]
Dtsch Med Wochenschr. 1995 Feb 24;120(8):239-44. doi: 10.1055/s-2008-1055339.
9
[Unusual defective antibody reaction after polio vaccination (author's transl)].[小儿麻痹症疫苗接种后异常的缺陷抗体反应(作者译)]
MMW Munch Med Wochenschr. 1975 Jan 17;117(3):83-6.
10
Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.在大规模疫苗接种运动与常规免疫规划中口服脊髓灰质炎疫苗的免疫原性。
Bull World Health Organ. 1995;73(6):769-77.

引用本文的文献

1
Is EU/EEA population protected from polio?欧盟/欧洲经济区的人口是否受到脊髓灰质炎的保护?
Hum Vaccin Immunother. 2015;11(9):2123-31. doi: 10.1080/21645515.2015.1016673. Epub 2015 Apr 21.
2
Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.中国新疆维吾尔自治区南部野生脊髓灰质炎病毒疫情期间脊髓灰质炎抗体血清学调查
PLoS One. 2014 Jul 3;9(7):e80069. doi: 10.1371/journal.pone.0080069. eCollection 2014.
3
Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.
中国边境省份15岁以下儿童中抗脊髓灰质炎抗体的血清流行率。
Clin Vaccine Immunol. 2013 Jul;20(7):1070-5. doi: 10.1128/CVI.00092-13. Epub 2013 May 15.
4
Expert review on poliovirus immunity and transmission.脊髓灰质炎病毒免疫与传播专家综述。
Risk Anal. 2013 Apr;33(4):544-605. doi: 10.1111/j.1539-6924.2012.01864.x. Epub 2012 Jul 15.
5
Poliomyelitis vaccination.脊髓灰质炎疫苗接种
Br Med J (Clin Res Ed). 1987 Jul 18;295(6591):158-9. doi: 10.1136/bmj.295.6591.158.
6
Prevalence of antibody to poliovirus in England and Wales 1984-6.1984 - 1986年英格兰和威尔士脊髓灰质炎病毒抗体的流行情况
Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1153-5. doi: 10.1136/bmj.293.6555.1153.